![BloodStream artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts123/v4/19/86/ba/1986ba60-84b2-4ee3-5c6c-e2f677b7ccdb/mza_5800774956923181338.png/100x100bb.jpg)
Highlights from ASH with Dr. Akshat Jain
BloodStream
English - March 08, 2024 08:00 - 44 minutes - 61.1 MB - ★★★★★ - 38 ratingsAlternative Health Health & Fitness advocacy biotech bleedingdisorders haemophilia healthcare hematology hemofilia hemophilia inhibitors insurance Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: HFA CEO Dan Kelsey and Rare Disease Day tribute
We’re back with Dr. Akshat Jain who shares highlights in bleeding disorder research from ASH 2023, plus the differences between hemophilia A vs hemophilia B gene therapies with Dr. Mark Redding. We close out with our latest Elite Athletes segments featuring bleeding disorder community legend, Perry Parker. Don’t miss it!
Show Notes:
Subscribe:
Presenting Sponsor:
Takeda, visit bleedingdisorders.com to learn more.
It’s a Whole New World Gene Therapy Segment brought to you by CSL Behring, which now has a first-of-its-kind hemophilia B treatment. Visit BeyondHemB.com or download B SUPPORT wherever you get your apps for more information.
Connect with BloodStream Media: